Cardiac Rehabilitation Devices Market

Dynamic technological innovations and advancements is driving the market growth

The increasing incidence of cardiovascular diseases globally is a primary driver for the Global Cardiac Rehabilitation Devices Market Industry. As heart disease remains a leading cause of mortality, the demand for effective rehabilitation solutions is surging. In 2024, the market is projected to reach 1.48 USD Billion, reflecting the urgent need for devices that support recovery and improve patient outcomes. This trend is likely to continue as healthcare systems prioritize cardiac rehabilitation to enhance quality of life and reduce healthcare costs associated with chronic heart conditions.

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The Asia Pacific Cardiac Rehabilitation Devices market dominated this market in 2022 (45.80%). This is a result of the region's expanding infrastructure, use of cutting-edge technology, rise in the number of people who place a high priority on exercise and health, and growing senior population. It is predicted that the adoption of technological innovation and expanded infrastructure will cause this increase. The need for cardiac rehabilitation equipment is increasing as the population ages and people's awareness of fitness and health grows.

Moreover, China’s Cardiac Rehabilitation Devices market held the largest market share, and the Indian Cardiac Rehabilitation Devices market was the fastest growing market in the Asia-Pacific region.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2  CARDIAC REHABILITATION DEVICES MARKET SHARE BY REGION 2022 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

The North America Cardiac Rehabilitation Devices Market is expected to register significant growth from 2024 to 2032. This is because cardiovascular disorders like hypertension, strokes, and coronary heart disease are becoming more prevalent in the area. The United States bears a disproportionately large share of the burden of cardiovascular disease in North America because of its sizable population and evolving lifestyle. The top cause of death in the US, according to estimates, is heart disease. Further, the U.S.

Cardiac Rehabilitation Devices market held the largest market share, and the Canada Cardiac Rehabilitation Devices market was the fastest growing market in the North America region.

Europe Cardiac Rehabilitation Devices market accounted for the healthy market share in 2023. The surge in product introductions is to blame for this. Additionally, a rise in the number of regulatory approvals in Europe's industrialised nations had a favourable impact on market expansion. Further, the German Cardiac Rehabilitation Devices market held the largest market share, and the U.K Cardiac Rehabilitation Devices market was the fastest growing market in the European region

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Cardiac Rehabilitation Devices market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Cardiac Rehabilitation Devices Industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  Cardiac Rehabilitation Devices Industry to benefit clients and increase the market sector. In recent years, the Cardiac Rehabilitation Devices Industry has offered some of the most significant advantages to medicine.

Major players in the Cardiac Rehabilitation Devices market, including Brunswick Corporation, Core Health & Fitness LLC, Amer Sports, OMRON Corporation, Honey well International Inc., The ScottCare Corporation, BioTelemetry Inc., Schiller, LSI, Ergoline GmbH, Scifit, Ball Dynamics International LLC, Core Health & Fitness LLC, Philips, Smiths Group, Halma plc., LifeWatch AG, and Patterson Companies Inc., are attempting to increase market demand by investing in research and development operations.

A company that offers molecular diagnostic testing services is Royal Philips Electronics. The business offers a platform for molecular diagnostic testing to examine illness samples. A milestone for the efforts to meet the needs to combat SCA (Sudden Cardiac Arrest) was reached in September 2019 when Royal Philips announced the shipment of its two million AEDs.

Halma is made up of 44 active firms that are all distributedly managed. The company strives to create a safer, cleaner, and healthier world through its goods. The organization's three business divisions are safety, environmental and analytical sciences, and healthcare. Smoke detectors, medical supplies, door sensors, and water purification are among Halma's offerings. The majority of the group's products are specialised and face little rivalry. The United States, Europe, and the United Kingdom account for more than 75% of sales. The London Stock Exchange lists Halma.

FluxData, which develops and produces cutting-edge digital and multispectral imaging systems for a variety of industries, including the industrial and medical sectors, was purchased by Halma plc in January 2017.